A detailed history of American Research & Management Co. transactions in Beyond Air, Inc. stock. As of the latest transaction made, American Research & Management Co. holds 500 shares of XAIR stock, worth $295. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$295
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

BUY
$8.44 - $15.61 $4,220 - $7,805
500 New
500 $5,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $17.6M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track American Research & Management Co. Portfolio

Follow American Research & Management Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.